Medical Care
Global Prostate Cancer Hormone Therapy Market Research Report 2025
- May 12, 25
- ID: 236205
- Pages: 89
- Figures: 85
- Views: 1
The global market for Prostate Cancer Hormone Therapy was valued at US$ 12920 million in the year 2024 and is projected to reach a revised size of US$ 21560 million by 2031, growing at a CAGR of 7.7% during the forecast period.
Hormone therapy for prostate cancer is a treatment that stops the hormone testosterone either from being made or from reaching prostate cancer cells. Most prostate cancer cells rely on testosterone to grow. Hormone therapy causes prostate cancer cells to die or to grow more slowly.
The prostate cancer hormone therapy market is evolving rapidly, driven by factors like:
Rising prostate cancer diagnosis: Prostate cancer remains the most common cancer among men in many countries. Early diagnosis and improved treatment options have contributed to increasing survival rates, fueling market growth.
Shifting treatment trends: Hormone therapy, which aims to lower testosterone levels and starve prostate cancer cells, is a cornerstone treatment for advanced and recurrent prostate cancer. Advancements in medication and targeted therapies are shaping the market landscape.
Personalized medicine: Growing understanding of cancer genomics and individual variations in response to therapy is leading to the development of personalized treatment plans, including targeted hormone therapies with fewer side effects.
Drug landscape: A variety of drugs belonging to different classes, like GnRH agonists, antagonists, and androgen receptor inhibitors, cater to diverse patient needs and treatment stages.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Hormone Therapy.
The Prostate Cancer Hormone Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Hormone Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Hormone Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ
Segment by Type
Tablet
Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Hormone Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hormone therapy for prostate cancer is a treatment that stops the hormone testosterone either from being made or from reaching prostate cancer cells. Most prostate cancer cells rely on testosterone to grow. Hormone therapy causes prostate cancer cells to die or to grow more slowly.
The prostate cancer hormone therapy market is evolving rapidly, driven by factors like:
Rising prostate cancer diagnosis: Prostate cancer remains the most common cancer among men in many countries. Early diagnosis and improved treatment options have contributed to increasing survival rates, fueling market growth.
Shifting treatment trends: Hormone therapy, which aims to lower testosterone levels and starve prostate cancer cells, is a cornerstone treatment for advanced and recurrent prostate cancer. Advancements in medication and targeted therapies are shaping the market landscape.
Personalized medicine: Growing understanding of cancer genomics and individual variations in response to therapy is leading to the development of personalized treatment plans, including targeted hormone therapies with fewer side effects.
Drug landscape: A variety of drugs belonging to different classes, like GnRH agonists, antagonists, and androgen receptor inhibitors, cater to diverse patient needs and treatment stages.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Hormone Therapy.
The Prostate Cancer Hormone Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Hormone Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Hormone Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Astellas
Johnson & Johnson
AstraZeneca
Bayer
Merck
Tolmar
Zoladex
Ferring Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
CTTQ
Segment by Type
Tablet
Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Hormone Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Hormone Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Prostate Cancer Hormone Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Hormone Therapy Market Perspective (2020-2031)
2.2 Global Prostate Cancer Hormone Therapy Growth Trends by Region
2.2.1 Global Prostate Cancer Hormone Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Hormone Therapy Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Hormone Therapy Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Hormone Therapy Market Dynamics
2.3.1 Prostate Cancer Hormone Therapy Industry Trends
2.3.2 Prostate Cancer Hormone Therapy Market Drivers
2.3.3 Prostate Cancer Hormone Therapy Market Challenges
2.3.4 Prostate Cancer Hormone Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Hormone Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Hormone Therapy Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Hormone Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Hormone Therapy Revenue
3.4 Global Prostate Cancer Hormone Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Hormone Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Hormone Therapy Revenue in 2024
3.5 Global Key Players of Prostate Cancer Hormone Therapy Head office and Area Served
3.6 Global Key Players of Prostate Cancer Hormone Therapy, Product and Application
3.7 Global Key Players of Prostate Cancer Hormone Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Hormone Therapy Breakdown Data by Type
4.1 Global Prostate Cancer Hormone Therapy Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Hormone Therapy Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Hormone Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Hormone Therapy Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Hormone Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Hormone Therapy Market Size (2020-2031)
6.2 North America Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Hormone Therapy Market Size (2020-2031)
7.2 Europe Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Hormone Therapy Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Hormone Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Hormone Therapy Market Size (2020-2031)
9.2 Latin America Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Hormone Therapy Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prostate Cancer Hormone Therapy Introduction
11.1.4 Pfizer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Astellas
11.2.1 Astellas Company Details
11.2.2 Astellas Business Overview
11.2.3 Astellas Prostate Cancer Hormone Therapy Introduction
11.2.4 Astellas Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.2.5 Astellas Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Hormone Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Prostate Cancer Hormone Therapy Introduction
11.4.4 AstraZeneca Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Prostate Cancer Hormone Therapy Introduction
11.5.4 Bayer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Prostate Cancer Hormone Therapy Introduction
11.6.4 Merck Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Tolmar
11.7.1 Tolmar Company Details
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Prostate Cancer Hormone Therapy Introduction
11.7.4 Tolmar Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.7.5 Tolmar Recent Development
11.8 Zoladex
11.8.1 Zoladex Company Details
11.8.2 Zoladex Business Overview
11.8.3 Zoladex Prostate Cancer Hormone Therapy Introduction
11.8.4 Zoladex Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.8.5 Zoladex Recent Development
11.9 Ferring Pharmaceuticals
11.9.1 Ferring Pharmaceuticals Company Details
11.9.2 Ferring Pharmaceuticals Business Overview
11.9.3 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Introduction
11.9.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.9.5 Ferring Pharmaceuticals Recent Development
11.10 Jiangsu Hengrui Pharmaceuticals
11.10.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Development
11.11 CTTQ
11.11.1 CTTQ Company Details
11.11.2 CTTQ Business Overview
11.11.3 CTTQ Prostate Cancer Hormone Therapy Introduction
11.11.4 CTTQ Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.11.5 CTTQ Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Hormone Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Prostate Cancer Hormone Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Hormone Therapy Market Perspective (2020-2031)
2.2 Global Prostate Cancer Hormone Therapy Growth Trends by Region
2.2.1 Global Prostate Cancer Hormone Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostate Cancer Hormone Therapy Historic Market Size by Region (2020-2025)
2.2.3 Prostate Cancer Hormone Therapy Forecasted Market Size by Region (2026-2031)
2.3 Prostate Cancer Hormone Therapy Market Dynamics
2.3.1 Prostate Cancer Hormone Therapy Industry Trends
2.3.2 Prostate Cancer Hormone Therapy Market Drivers
2.3.3 Prostate Cancer Hormone Therapy Market Challenges
2.3.4 Prostate Cancer Hormone Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Hormone Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Hormone Therapy Players by Revenue (2020-2025)
3.1.2 Global Prostate Cancer Hormone Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Prostate Cancer Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostate Cancer Hormone Therapy Revenue
3.4 Global Prostate Cancer Hormone Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Hormone Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Hormone Therapy Revenue in 2024
3.5 Global Key Players of Prostate Cancer Hormone Therapy Head office and Area Served
3.6 Global Key Players of Prostate Cancer Hormone Therapy, Product and Application
3.7 Global Key Players of Prostate Cancer Hormone Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Hormone Therapy Breakdown Data by Type
4.1 Global Prostate Cancer Hormone Therapy Historic Market Size by Type (2020-2025)
4.2 Global Prostate Cancer Hormone Therapy Forecasted Market Size by Type (2026-2031)
5 Prostate Cancer Hormone Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Hormone Therapy Historic Market Size by Application (2020-2025)
5.2 Global Prostate Cancer Hormone Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostate Cancer Hormone Therapy Market Size (2020-2031)
6.2 North America Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
6.4 North America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Hormone Therapy Market Size (2020-2031)
7.2 Europe Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
7.4 Europe Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Hormone Therapy Market Size (2020-2031)
8.2 Asia-Pacific Prostate Cancer Hormone Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Hormone Therapy Market Size (2020-2031)
9.2 Latin America Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
9.4 Latin America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Hormone Therapy Market Size (2020-2031)
10.2 Middle East & Africa Prostate Cancer Hormone Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prostate Cancer Hormone Therapy Introduction
11.1.4 Pfizer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Astellas
11.2.1 Astellas Company Details
11.2.2 Astellas Business Overview
11.2.3 Astellas Prostate Cancer Hormone Therapy Introduction
11.2.4 Astellas Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.2.5 Astellas Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Hormone Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Prostate Cancer Hormone Therapy Introduction
11.4.4 AstraZeneca Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Prostate Cancer Hormone Therapy Introduction
11.5.4 Bayer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Prostate Cancer Hormone Therapy Introduction
11.6.4 Merck Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Tolmar
11.7.1 Tolmar Company Details
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Prostate Cancer Hormone Therapy Introduction
11.7.4 Tolmar Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.7.5 Tolmar Recent Development
11.8 Zoladex
11.8.1 Zoladex Company Details
11.8.2 Zoladex Business Overview
11.8.3 Zoladex Prostate Cancer Hormone Therapy Introduction
11.8.4 Zoladex Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.8.5 Zoladex Recent Development
11.9 Ferring Pharmaceuticals
11.9.1 Ferring Pharmaceuticals Company Details
11.9.2 Ferring Pharmaceuticals Business Overview
11.9.3 Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Introduction
11.9.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.9.5 Ferring Pharmaceuticals Recent Development
11.10 Jiangsu Hengrui Pharmaceuticals
11.10.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.10.3 Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Introduction
11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Development
11.11 CTTQ
11.11.1 CTTQ Company Details
11.11.2 CTTQ Business Overview
11.11.3 CTTQ Prostate Cancer Hormone Therapy Introduction
11.11.4 CTTQ Revenue in Prostate Cancer Hormone Therapy Business (2020-2025)
11.11.5 CTTQ Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Hormone Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global Prostate Cancer Hormone Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Prostate Cancer Hormone Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Prostate Cancer Hormone Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Prostate Cancer Hormone Therapy Market Share by Region (2020-2025)
Table 8. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Prostate Cancer Hormone Therapy Market Share by Region (2026-2031)
Table 10. Prostate Cancer Hormone Therapy Market Trends
Table 11. Prostate Cancer Hormone Therapy Market Drivers
Table 12. Prostate Cancer Hormone Therapy Market Challenges
Table 13. Prostate Cancer Hormone Therapy Market Restraints
Table 14. Global Prostate Cancer Hormone Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Prostate Cancer Hormone Therapy Market Share by Players (2020-2025)
Table 16. Global Top Prostate Cancer Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Hormone Therapy as of 2024)
Table 17. Ranking of Global Top Prostate Cancer Hormone Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Hormone Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Prostate Cancer Hormone Therapy, Headquarters and Area Served
Table 20. Global Key Players of Prostate Cancer Hormone Therapy, Product and Application
Table 21. Global Key Players of Prostate Cancer Hormone Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Hormone Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Prostate Cancer Hormone Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Prostate Cancer Hormone Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Prostate Cancer Hormone Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Prostate Cancer Hormone Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Prostate Cancer Hormone Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Prostate Cancer Hormone Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Prostate Cancer Hormone Therapy Product
Table 49. Pfizer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Astellas Company Details
Table 52. Astellas Business Overview
Table 53. Astellas Prostate Cancer Hormone Therapy Product
Table 54. Astellas Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 55. Astellas Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Prostate Cancer Hormone Therapy Product
Table 59. Johnson & Johnson Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Prostate Cancer Hormone Therapy Product
Table 64. AstraZeneca Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Prostate Cancer Hormone Therapy Product
Table 69. Bayer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Prostate Cancer Hormone Therapy Product
Table 74. Merck Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Tolmar Company Details
Table 77. Tolmar Business Overview
Table 78. Tolmar Prostate Cancer Hormone Therapy Product
Table 79. Tolmar Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 80. Tolmar Recent Development
Table 81. Zoladex Company Details
Table 82. Zoladex Business Overview
Table 83. Zoladex Prostate Cancer Hormone Therapy Product
Table 84. Zoladex Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 85. Zoladex Recent Development
Table 86. Ferring Pharmaceuticals Company Details
Table 87. Ferring Pharmaceuticals Business Overview
Table 88. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Product
Table 89. Ferring Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 90. Ferring Pharmaceuticals Recent Development
Table 91. Jiangsu Hengrui Pharmaceuticals Company Details
Table 92. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 93. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Product
Table 94. Jiangsu Hengrui Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 95. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 96. CTTQ Company Details
Table 97. CTTQ Business Overview
Table 98. CTTQ Prostate Cancer Hormone Therapy Product
Table 99. CTTQ Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 100. CTTQ Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Prostate Cancer Hormone Therapy Picture
Figure 2. Global Prostate Cancer Hormone Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Cancer Hormone Therapy Market Share by Type: 2024 VS 2031
Figure 4. Tablet Features
Figure 5. Injection Features
Figure 6. Global Prostate Cancer Hormone Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Prostate Cancer Hormone Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Prostate Cancer Hormone Therapy Report Years Considered
Figure 12. Global Prostate Cancer Hormone Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Prostate Cancer Hormone Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Prostate Cancer Hormone Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Prostate Cancer Hormone Therapy Market Share by Players in 2024
Figure 16. Global Top Prostate Cancer Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Hormone Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Hormone Therapy Revenue in 2024
Figure 18. North America Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 20. United States Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 24. Germany Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Hormone Therapy Market Share by Region (2020-2031)
Figure 32. China Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 48. Astellas Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 50. AstraZeneca Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 52. Merck Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 53. Tolmar Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 54. Zoladex Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 55. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 56. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 57. CTTQ Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Prostate Cancer Hormone Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global Prostate Cancer Hormone Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Prostate Cancer Hormone Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Prostate Cancer Hormone Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Prostate Cancer Hormone Therapy Market Share by Region (2020-2025)
Table 8. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Prostate Cancer Hormone Therapy Market Share by Region (2026-2031)
Table 10. Prostate Cancer Hormone Therapy Market Trends
Table 11. Prostate Cancer Hormone Therapy Market Drivers
Table 12. Prostate Cancer Hormone Therapy Market Challenges
Table 13. Prostate Cancer Hormone Therapy Market Restraints
Table 14. Global Prostate Cancer Hormone Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Prostate Cancer Hormone Therapy Market Share by Players (2020-2025)
Table 16. Global Top Prostate Cancer Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Hormone Therapy as of 2024)
Table 17. Ranking of Global Top Prostate Cancer Hormone Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Hormone Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Prostate Cancer Hormone Therapy, Headquarters and Area Served
Table 20. Global Key Players of Prostate Cancer Hormone Therapy, Product and Application
Table 21. Global Key Players of Prostate Cancer Hormone Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Hormone Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Prostate Cancer Hormone Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Prostate Cancer Hormone Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Prostate Cancer Hormone Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Prostate Cancer Hormone Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Prostate Cancer Hormone Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Prostate Cancer Hormone Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Prostate Cancer Hormone Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Hormone Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Prostate Cancer Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Hormone Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Prostate Cancer Hormone Therapy Product
Table 49. Pfizer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Astellas Company Details
Table 52. Astellas Business Overview
Table 53. Astellas Prostate Cancer Hormone Therapy Product
Table 54. Astellas Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 55. Astellas Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Prostate Cancer Hormone Therapy Product
Table 59. Johnson & Johnson Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Prostate Cancer Hormone Therapy Product
Table 64. AstraZeneca Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Prostate Cancer Hormone Therapy Product
Table 69. Bayer Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Prostate Cancer Hormone Therapy Product
Table 74. Merck Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Tolmar Company Details
Table 77. Tolmar Business Overview
Table 78. Tolmar Prostate Cancer Hormone Therapy Product
Table 79. Tolmar Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 80. Tolmar Recent Development
Table 81. Zoladex Company Details
Table 82. Zoladex Business Overview
Table 83. Zoladex Prostate Cancer Hormone Therapy Product
Table 84. Zoladex Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 85. Zoladex Recent Development
Table 86. Ferring Pharmaceuticals Company Details
Table 87. Ferring Pharmaceuticals Business Overview
Table 88. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Product
Table 89. Ferring Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 90. Ferring Pharmaceuticals Recent Development
Table 91. Jiangsu Hengrui Pharmaceuticals Company Details
Table 92. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 93. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Product
Table 94. Jiangsu Hengrui Pharmaceuticals Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 95. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 96. CTTQ Company Details
Table 97. CTTQ Business Overview
Table 98. CTTQ Prostate Cancer Hormone Therapy Product
Table 99. CTTQ Revenue in Prostate Cancer Hormone Therapy Business (2020-2025) & (US$ Million)
Table 100. CTTQ Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Prostate Cancer Hormone Therapy Picture
Figure 2. Global Prostate Cancer Hormone Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Prostate Cancer Hormone Therapy Market Share by Type: 2024 VS 2031
Figure 4. Tablet Features
Figure 5. Injection Features
Figure 6. Global Prostate Cancer Hormone Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Prostate Cancer Hormone Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Prostate Cancer Hormone Therapy Report Years Considered
Figure 12. Global Prostate Cancer Hormone Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Prostate Cancer Hormone Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Prostate Cancer Hormone Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Prostate Cancer Hormone Therapy Market Share by Players in 2024
Figure 16. Global Top Prostate Cancer Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Hormone Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Hormone Therapy Revenue in 2024
Figure 18. North America Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 20. United States Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 24. Germany Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Hormone Therapy Market Share by Region (2020-2031)
Figure 32. China Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Hormone Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Prostate Cancer Hormone Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 48. Astellas Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 50. AstraZeneca Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 52. Merck Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 53. Tolmar Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 54. Zoladex Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 55. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 56. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 57. CTTQ Revenue Growth Rate in Prostate Cancer Hormone Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232